25.10.2021 • News

BioNTech Founders in German Research Hall of Fame

Özlem Türeci and Uğur Şahin, founders and managing board members of Mainz-based BioNTech, were inducted into the Hall of Fame of German Research (Hall of Fame der deutschen Forschung) on Oct. 21. The awards ceremony in Wiesbaden, Germany, was organized by German pharmaceuticals, chemicals and life sciences group Merck together with Manager Magazin.

The principals of the company that developed the first mRNA-based Covid-19 vaccine to be approved by regulatory authorities worldwide have done outstanding research for decades and are true pioneers in medicine, Merck CEO Belén Garijo said at the ceremony. “Based on this technology, she said, “the door to an effective treatment of cancer and to new vaccines for infectious diseases is now wide open. Their work has been indispensable in bringing the Covid-19 pandemic to a halt.”

Author: Dede Williams, Freelance Journalist

 

Özlem Türeci and Uğur Şahin, founders and managing board members of Covid...
Özlem Türeci and Uğur Şahin, founders and managing board members of Covid vaccine maker BioNTech, were inducted into the Hall of Fame of German Research on Oct. 21. The awards were presented by German pharmaceuticals, chemicals and life sciences group Merck and Manager Magazin. (c) Merck Group

Company

Logo:

Merck KGaA

Frankfurter Str. 250
64293 Darmstadt
Germany

Company contact







Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

most read